Registering Class D medical devices in Saudi Arabia is a detailed and regulated process governed by the Saudi Food and Drug Authority (SFDA). Class D represents the highest-risk category of medical devices, such as implantable, life-supporting, or invasive products. The registration process is rigorous and involves multiple steps, specific documents, and careful compliance with national regulations.
Use SFDA’s classification rules based on IMDRF/GHTF principles.
Class D includes devices with the highest risk: e.g., pacemakers, orthopedic implants, dialysis machines, ventilators.
Foreign manufacturers must appoint a Saudi-based LAR.
The LAR acts as the legal contact with SFDA and submits applications.
LAR must obtain an Establishment License (EL).
Apply through the GHAD system: https://ghad.sfda.gov.sa
The LAR and manufacturer must be registered.
The EL is mandatory before registering any devices.
Build a complete technical file (design dossier) per SFDA guidelines.
This includes safety, performance, risk management, and clinical data.
Portal: https://mdnr.sfda.gov.sa
Upload documents and complete the online registration form.
Pay registration fees and submit for SFDA review.
SFDA conducts a comprehensive review, including:
Technical & safety assessment
Clinical evidence verification
Labeling and IFU compliance
Potential QMS audits for high-risk devices
Duration: 6–12 months, depending on completeness and complexity
Once approved, SFDA issues a Medical Device Marketing Authorization (MDMA).
Required for product import and commercial distribution.
Implement vigilance and adverse event reporting.
Maintain product traceability and field safety corrective actions (FSCA).
Renew MDMA as required (usually valid for 3–5 years).
Device description and specifications
Design dossier (full technical file)
Risk Management Report (ISO 14971)
Clinical Evaluation Report (CER)
Biocompatibility, sterilization, software validation (if applicable)
Performance and safety test reports (e.g., IEC 60601, ISO 10993, etc.)
ISO 13485 certificate (valid and issued by SFDA-recognized body)
Declaration of Conformity (DoC)
CE Certificate or other approval (e.g., FDA 510(k), TGA, etc.)
Certificate of Free Sale (from country of origin)
Market history or proof of commercialization in other countries
Product labels (Arabic and English)
Instructions for Use (Arabic and English)
UDI (if applicable)
LAR appointment letter
Commercial registration (CR) certificate of the LAR
Establishment License (EL) from GHAD
Application form and fee payment receipt
Class D devices undergo in-depth technical and clinical review.
In some cases, SFDA may require:
Product-specific testing
Site audits
Batch release inspections (especially for sterile/implantable products)
Clinical Evaluation Report (CER) must follow recognized guidelines.
New or high-risk technologies may require local clinical trials or additional data.
SFDA mandates bilingual labeling (Arabic + English).
Noncompliant labeling is a common cause of delay.
The LAR must report serious incidents and maintain vigilance files.
Maintain PMS procedures in accordance with SFDA guidelines.
| Aspect | Estimate |
|---|---|
| Timeframe | 6–12 months |
| SFDA Fees | SAR 25,000 – 40,000 (~USD 6,700–10,700) |
| Other Costs | Consultant, translation, testing, etc. |
| Stage | Key Actions |
|---|---|
| Classification | Confirm Class D under SFDA rules |
| LAR Appointment | Saudi-based representative required |
| Establishment Licensing | Apply via GHAD portal |
| Technical File Preparation | Dossier, CER, QMS, DoC, performance tests |
| Registration Submission | Upload via MDNR platform |
| SFDA Review & Clarification | Expect queries, possible audits or testing requests |
| MDMA Certificate Issuance | Device officially approved for sale/import |
| Post-Market Surveillance | Ensure reporting, renewals, traceability |
Would you like templates for the CER, DoC, or a checklist to guide your Class D registration project? I can also assist in identifying qualified LARs or regulatory consultants in Saudi Arabia.
.jpg)
Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn